LSNE Contract Manufacturing

What LSNE Contract Manufacturing does

LSNE Contract Manufacturing operates as the lyophilization and sterile fill-finish division of PCI Pharma Services (Packaging Coordinators, LLC), a global contract development and manufacturing organization (CDMO) serving pharmaceutical and biotechnology companies from early-stage development through commercialization. The company's core offering spans sterile drug development and manufacturing (including lyophilization cycle development, sterile fill-finish, prefilled syringes, and complex formulations), non-sterile development and manufacturing for oral and high-potency dosage forms, clinical trial supply chain services, and commercial packaging technology with serialization and anti-counterfeiting capabilities. Proprietary technology includes the pci|bridge digital platform providing real-time supply chain visibility, integrated with MasterControl quality management systems, DocuSign for document workflows, and Smartsheet for project tracking, alongside a portfolio of branded compliance packaging formats such as Dosepak, Shellpak, IntuiDose, and EcoSlide.

Operating 38 GMP-compliant facilities across 7 countries (United States, Canada, United Kingdom, Ireland, Germany, Spain, and Australia) with over 8,000 employees, LSNE/PCI serves established pharmaceutical companies and biotech firms requiring regulatory-compliant manufacturing, serialization across 80+ global packaging lines, cold chain logistics for biologics, and end-to-end new product introduction support for 90+ product launches annually. The business model is project-based with multi-year contracts, capacity reservation fees, monthly invoicing for project management and storage, and batch record-based invoicing for manufacturing and packaging services. Revenue is generated through professional services engagements distributed via direct enterprise sales teams, with no intermediaries. PCI has expanded through a programmatic acquisition strategy since 2017, acquiring AndersonBrecon, LSNE, Penn Pharmaceutical Services, Biotec Services International, Sherpa Clinical Packaging, Millmount Healthcare, and Pharmaceutical Packaging Professionals to build its integrated global CDMO platform.

Name

LSNE Contract Manufacturing

Legal name

Packaging Coordinators, LLC

Website

https://pci.com

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

101–250 employees

Short description

LSNE Contract Manufacturing is the lyophilization and sterile fill-finish division of PCI Pharma Services, a global CDMO serving pharma and biotech companies with sterile and non-sterile drug development, manufacturing, clinical supply, and serialization across 38 GMP facilities in 7 countries.

Ownership category

akta.pro rank

Product category

Contract Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)

akta.pro secondary industries

Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL), Process Development & Tech Transfer Services (CDMO) (HLAGABAL)

Keywords

• Contract pharmaceutical manufacturing
• Sterile fill-finish services
• Lyophilization cycle development
• Clinical supply packaging
• Pharmaceutical CDMO services

Headquarters

HQ city

Bedford, New Hampshire

HQ country

United States

HQ region

North America

Offices15 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Development and Manufacturing Services: PCI provides end-to-end CDMO services including sterile and non-sterile development and manufacturing, clinical trial services, and commercial packaging technology. Revenue is generated through project-based contracts, capacity reservation fees, and service fees for manufacturing, packaging, storage, and distribution.
2. Sterile Fill-Finish and Lyophilization: Manufacturing services for sterile drug products including fill-finish operations, lyophilization cycle development, and bulk lyophilization for clinical and commercial supply.
3. Clinical Trial Services: Clinical supply chain management, temperature-controlled packaging, cold chain logistics, and clinical trial support services billed on project basis.
4. Commercial Packaging Technology: Serialization, compliance packaging, drug-device combination assembly, and launch services for commercial pharmaceutical products.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

LSNE Contract Manufacturing operates as a division of PCI Pharma Services providing lyophilization and sterile contract manufacturing services for pharmaceutical and biotechnology clients. The company specializes in sterile fill-finish, bulk lyophilization, lyophilization cycle development, prefilled syringe services, and complex sterile formulations for injectable drug products serving clinical and commercial supply needs.

Product overview

PCI Pharma Services operates as a global Contract Development and Manufacturing Organization (CDMO) offering integrated pharmaceutical services across sterile and non-sterile product categories. The portfolio is organized around core service lines—Sterile Services (including development, manufacturing, fill-finish, lyophilization, and prefilled syringes) and Non-Sterile Services (covering development, high-potent manufacturing, and oral therapies)—supplemented by clinical trial services, commercial packaging technology, and Quality & Regulatory Services. The pci | bridge™ digital platform provides real-time supply chain visibility and integrates with DocuSign and Smartsheet for document management and project tracking. Proprietary packaging solutions include clinicalSMART™ for clinical supply management and various branded adherence packaging formats (IntuiDose™, IntuiPac™, DuraPac™, CIAB™, AssuraDose™, RxBarrier™, HingePac™). The SpeedSolutions™ brand encompasses the company's integrated approach to accelerating development through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

• IntuiDose™: Carded blister with push-through dispensing, calendar tracking, and integrated education space for patient compliance
• IntuiPac™
• DuraPac™
• CIAB™
• AssuraDose™
• RxBarrier™
• HingePac™
• clinicalSMART™
• Activ-Blister™
• Dosepak™
• Shellpak™
• KeyPak™
• Perfpak™
• EcoSlide™
• pci | bridge™
• SpeedSolutions™
• expertXchange™

Products and services

• Sterile Fill-Finish & Lyophilization

Quantifiable outcome

• 90+ product launches supported per year
• +5 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and support.

• Antares VisioncoreTechnology or IntegrationStrategic partnership for serialization technology solutions. PCI leverages Antares Vision's technology as part of their multi-layered serialization capabilities across 80+ global serialization lines, ensuring compliance with complex regulatory requirements for pharmaceutical serialization and anti-counterfeiting.
• DocuSigncoreTechnology or IntegrationIntegration within pci|bridge platform enabling clients to review, approve, and electronically sign documents directly within the platform. Every action is tracked and time-stamped to ensure compliance, clarity, and full document control.
• SmartsheetsupportTechnology or IntegrationIntegrated within pci|bridge platform for project visibility and collaborative work management, providing clients with integrated project tracking alongside other supply chain data.
• MasterControlcoreTechnology or IntegrationValidated quality management system forming part of PCI's digital quality framework, which unifies Electronic Batch Records, LIMS, and MES into a single ecosystem.
• GS1coreStrategic or Co-development PartnerActive participation in GS1 global standards body ensures ongoing compliance with evolving serialization regulations worldwide, contributing to industry standards development.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Almac Group: Integrated CDMO providing clinical trial supply, commercial manufacturing, and serialization. Direct competitor to PCI in clinicalSMART™ and commercial packaging.
• WuXi AppTec / WuXi STA: Global CDMO with large-scale sterile injectable and small-molecule manufacturing. Directly competes with PCI in CDMO Leadership Award categories and shared pharma client base.
• Aenova Group: European CDMO offering solid dosage forms, sterile manufacturing, and packaging. Competes with PCI for European pharma and biotech clinical-to-commercial work.
• Vetter Pharma: Germany-based specialist in sterile fill-finish of injectable drugs, including prefilled syringes. Directly comparable to PCI's sterile services and advanced drug delivery offerings.
• Catalent: Global CDMO offering sterile fill-finish, biologics development, and commercial packaging. Recently acquired by Novo Holdings, making it one of the largest direct competitors to PCI across sterile and biologic manufacturing services.
• CordenPharma: Global CDMO covering APIs, drug products, and packaging including sterile injectables. Comparable to PCI in sterile fill-finish and complex formulation services.
• Baxter BioPharma Solutions: Contract manufacturing services within Baxter specializing in sterile injectables, prefilled syringes, and lyophilized products. Directly comparable to PCI's sterile fill-finish and advanced drug delivery offerings.
• Recipharm: European-headquartered CDMO providing sterile fill-finish, lyophilization, and commercial packaging. Closely comparable to PCI's LSNE and AndersonBrecon operations.

Broad incumbents

• Thermo Fisher Scientific (Patheon): Pharma services division through Patheon offers clinical and commercial manufacturing, packaging, and serialization. Competes with PCI for integrated pharma outsourcing deals.
• Lonza Group: World's largest CDMO with deep biologics, cell and gene, and small-molecule capabilities. A broad incumbent competing with PCI across sterile fill-finish, lyophilization, and commercial packaging.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lsne-contract-manufacturing

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LSNE Contract Manufacturing